loading

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
18.24%
17.63
21.56 21.95 23.38 23.71
Operating Income/Loss
18.24%
-17.63
-21.56 -21.95 -23.38 -23.71
Income/Loss From Continuing Operations Before Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Net Income/Loss
18.11%
-16.56
-20.22 -20.31 -21.55 -21.66
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Diluted Average Shares
222.77K%
7.3057
0.00328 7.2962 72.85 72.80
Basic Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Diluted Earnings Per Share
18.05%
-2.27
-2.77 -2.78 -0.30 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.47
price up icon 0.77%
$31.75
price down icon 0.87%
$102.75
price up icon 2.31%
$96.24
price up icon 0.24%
biotechnology ONC
$321.95
price down icon 2.83%
$205.45
price up icon 0.37%
Kapitalisierung:     |  Volumen (24h):